Trial intelligence / Profile preview

Topical simvastatin gel versus placebo for acne vulgaris

IRCT20100119003106N38Phase 3Completed

Sponsor
Islamic Azad University
Start
Jul 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of simvastatin in acne vulgaris, sponsored by Islamic Azad University. Primary endpoints: Reduction in inflammatory acne lesions, Change in Global Acne Grading System score and 1 more. Started Jul 2018; status: completed.

02

Drugs

simvastatin
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on IRCT20100119003106N38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20100119003106N38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call